Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosis.
Reginster
J Y
JY
Compston
J E
JE
Jones
E A
EA
Kaufman
J M
JM
Audran
M
M
Bouvenot
G
G
Frati
L
L
Mazzuoli
G
G
Gennari
C
C
Lemmel
E M
EM
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects / Q000502:physiology; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000517:prevention & control